JPWO2019194130A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019194130A5
JPWO2019194130A5 JP2020512235A JP2020512235A JPWO2019194130A5 JP WO2019194130 A5 JPWO2019194130 A5 JP WO2019194130A5 JP 2020512235 A JP2020512235 A JP 2020512235A JP 2020512235 A JP2020512235 A JP 2020512235A JP WO2019194130 A5 JPWO2019194130 A5 JP WO2019194130A5
Authority
JP
Japan
Prior art keywords
mucin
type glycoprotein
mol
increasing
bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020512235A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019194130A1 (ja
JP7464931B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/014480 external-priority patent/WO2019194130A1/ja
Publication of JPWO2019194130A1 publication Critical patent/JPWO2019194130A1/ja
Publication of JPWO2019194130A5 publication Critical patent/JPWO2019194130A5/ja
Application granted granted Critical
Publication of JP7464931B2 publication Critical patent/JP7464931B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020512235A 2018-04-05 2019-04-01 新規ムチン型糖タンパク質およびその用途 Active JP7464931B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018073308 2018-04-05
JP2018073308 2018-04-05
PCT/JP2019/014480 WO2019194130A1 (ja) 2018-04-05 2019-04-01 新規ムチン型糖タンパク質およびその用途

Publications (3)

Publication Number Publication Date
JPWO2019194130A1 JPWO2019194130A1 (ja) 2021-04-08
JPWO2019194130A5 true JPWO2019194130A5 (cg-RX-API-DMAC7.html) 2022-06-06
JP7464931B2 JP7464931B2 (ja) 2024-04-10

Family

ID=68100507

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020512235A Active JP7464931B2 (ja) 2018-04-05 2019-04-01 新規ムチン型糖タンパク質およびその用途

Country Status (2)

Country Link
JP (1) JP7464931B2 (cg-RX-API-DMAC7.html)
WO (1) WO2019194130A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250213600A1 (en) 2022-03-18 2025-07-03 Meiji Co., Ltd. Composition for controlling growth of bacteria in the intestinal tract and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010107083A1 (ja) 2009-03-19 2010-09-23 丸共バイオフーズ株式会社 抗原特異的ｔ細胞の増殖促進剤
PL3443071T3 (pl) 2016-04-11 2022-03-28 Wageningen Universiteit Nowe gatunki bakterii

Similar Documents

Publication Publication Date Title
Busscher et al. Biofilm formation on dental restorative and implant materials
Philip et al. Ecological approaches to dental caries prevention: paradigm shift or shibboleth?
Borzabadi-Farahani et al. Nanoparticles in orthodontics, a review of antimicrobial and anti-caries applications
Sodagar et al. Effect of addition of curcumin nanoparticles on antimicrobial property and shear bond strength of orthodontic composite to bovine enamel
JP2023501627A5 (cg-RX-API-DMAC7.html)
MXPA05009933A (es) Composiciones que comprenden acidos grasos y aminoacidos.
EP2636404A3 (en) Methods of Treating Non-Alcoholic Steatohepatitis (Nash) Using Cysteamine Products
McClure The Destructive Action, in Vivo, of Dilute Acids and Acid Drinks and Beverages on the Rats' Molar Teeth: One Plate (Eight Figures)
JP2018012722A5 (cg-RX-API-DMAC7.html)
PH12021550331A1 (en) Acylated calcitonin mimetics
EP4445951A3 (en) Methods and compositions for treating sleep apnea
JP2018519366A5 (cg-RX-API-DMAC7.html)
JP2016525548A5 (cg-RX-API-DMAC7.html)
EP4233913A3 (en) Improved bromocriptine formulations
JPWO2019194130A5 (cg-RX-API-DMAC7.html)
JP2013538856A5 (cg-RX-API-DMAC7.html)
JP2005524629A5 (cg-RX-API-DMAC7.html)
WO2018078599A3 (en) Composition for the preventive or curative treatment of liver disorders
RU2007137845A (ru) Дерматологическое применение молочных белков
JP7084627B2 (ja) ウイルス感染症予防用組成物
WO2012049430A3 (fr) Hydrolysats de proteines animales d'origine marine aux proprietes neuroprotectrices
JP2016210758A5 (cg-RX-API-DMAC7.html)
JP2017007966A5 (cg-RX-API-DMAC7.html)
TWI640314B (zh) 戈氏副擬桿菌用於降低胰島素抗性及提升葡萄糖耐受性之用途
JP2022047701A (ja) ラクトパーオキシダーゼ及びグルコースオキシダーゼを含む組成物